发明名称 |
Bacterial composition |
摘要 |
A bacterial composition that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 STECs that include E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111. The composition is constituted of various combinations of the following four unique pathogen-inhibiting bacteria: (1) Lactobacillus animalis strain MB101; (2) Lactobacillus animalis strain MB102; (3) Enterococcus faecium strain MB505; and (4) Pediococcus acidilactici strain MB902. Each of the discovered bacteria is deposited with the American Type Culture Collection (ATCC) and respectively has an individual ATCC Accession Number. |
申请公布号 |
US9278115(B2) |
申请公布日期 |
2016.03.08 |
申请号 |
US201414587705 |
申请日期 |
2014.12.31 |
申请人 |
MICROBIOS, INC. |
发明人 |
Flint Joseph F.;Garner Matthew Ryan |
分类号 |
A01N63/00;A61K35/747;A61K35/742;A61K35/744;A23K1/00;A23K1/18 |
主分类号 |
A01N63/00 |
代理机构 |
Novak Druce Connolly Bove + Quigg LLP |
代理人 |
Novak Druce Connolly Bove + Quigg LLP |
主权项 |
1. A composition comprising a mixture having equal viable numbers of each of the following four bacteria: Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710; Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711; Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709; and Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712; and wherein the mixture has an E. coli 0157:H7 growth inhibition rate of at least 93.1% when mixed with an equal number of viable E. coli 0157:H7 bacteria relative to the total number of viable bacteria comprised by the four bacteria of the mixture. |
地址 |
Houston TX US |